Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 73

1.

Management of metastatic castration-resistant prostate cancer: A focus on radium-223: Opinions and suggestions from an expert multidisciplinary panel.

Baldari S, Boni G, Bortolus R, Caffo O, Conti G, De Vincentis G, Monari F, Procopio G, Santini D, Seregni E, Valdagni R.

Crit Rev Oncol Hematol. 2017 May;113:43-51. doi: 10.1016/j.critrevonc.2017.03.001. Epub 2017 Mar 6. Review.

PMID:
28427521
2.

Pros-IT CNR: an Italian prostate cancer monitoring project.

Noale M, Maggi S, Artibani W, Bassi PF, Bertoni F, Bracarda S, Conti GN, Corvò R, Gacci M, Graziotti P, Magrini SM, Maurizi Enrici R, Mirone V, Montironi R, Muto G, Pecoraro S, Porreca A, Ricardi U, Tubaro A, Zagonel V, Zattoni F, Crepaldi G; Pros-IT CNR study group..

Aging Clin Exp Res. 2017 Apr;29(2):165-172. doi: 10.1007/s40520-017-0735-6. Epub 2017 Feb 24.

PMID:
28236267
3.

Impact of DNA repair gene polymorphisms on the risk of biochemical recurrence after radiotherapy and overall survival in prostate cancer.

Zanusso C, Bortolus R, Dreussi E, Polesel J, Montico M, Cecchin E, Gagno S, Rizzolio F, Arcicasa M, Novara G, Toffoli G.

Oncotarget. 2017 Apr 4;8(14):22863-22875. doi: 10.18632/oncotarget.15282.

4.

Why women do not ask for information on preconception health? A qualitative study.

Bortolus R, Oprandi NC, Rech Morassutti F, Marchetto L, Filippini F, Agricola E, Tozzi AE, Castellani C, Lalatta F, Rusticali B, Mastroiacovo P.

BMC Pregnancy Childbirth. 2017 Jan 5;17(1):5. doi: 10.1186/s12884-016-1198-z.

5.

Folate, homocysteine and selected vitamins and minerals status in infertile women.

La Vecchia I, Paffoni A, Castiglioni M, Ferrari S, Bortolus R, Ferraris Fusarini C, Bettinardi N, Somigliana E, Parazzini F.

Eur J Contracept Reprod Health Care. 2017 Feb;22(1):70-75. doi: 10.1080/13625187.2016.1263292. Epub 2016 Dec 15.

PMID:
27976929
6.

Adaptation and validation of an Italian version of the Prostate Cancer Specific Quality of Life Instrument (PROSQOLI).

Bellardita L, Damiano R, Porpiglia F, Scattoni V, Amodeo A, Bortolus R, Lapini A, Cocci A, Cicalese V, Caponera M, Mastrangelo P, Francesca F, Valdagni R, Taverna G, di Trapani D, Leonardi R, Minocci D, Gaboardi F, Montanari E, Conti G.

Eur Rev Med Pharmacol Sci. 2016 Jul;20(13):2773-8.

7.

Prevalence of Cardiovascular Disease and Osteoporosis During Androgen Deprivation Therapy Prescription Discordant to EAU Guidelines: Results From a Multicenter, Cross-sectional Analysis From the CHOsIng Treatment for Prostate canCEr (CHOICE) Study.

Morgia G, Russo GI, Tubaro A, Bortolus R, Randone D, Gabriele P, Trippa F, Zattoni F, Porena M, Mirone V, Serni S, Del Nero A, Lay G, Ricardi U, Rocco F, Terrone C, Pagliarulo A, Ludovico G, Vespasiani G, Brausi M, Simeone C, Novella G, Carmignani G, Leonardi R, Pinnarò P, De Paula U, Corvò R, Tenaglia R, Siracusano S, Mantini G, Gontero P, Savoca G, Ficarra V; L. U. N. A. Foundation and Società Italiana d'Urologia)..

Urology. 2016 Oct;96:165-170. doi: 10.1016/j.urology.2016.06.024. Epub 2016 Jul 8.

PMID:
27402374
8.

Diagnostic value of neutrophil gelatinase-associated lipocalin/matrix metalloproteinase-9 pathway in transitional cell carcinoma of the bladder.

Candido S, Di Maso M, Serraino D, McCubrey JA, Bortolus R, Zanin M, Battiston M, Salemi R, Libra M, Polesel J.

Tumour Biol. 2016 Jul;37(7):9855-63. doi: 10.1007/s13277-016-4872-x. Epub 2016 Jan 26.

PMID:
26810191
9.

Clinical outcomes in octogenarians treated with docetaxel as first-line chemotherapy for castration-resistant prostate cancer.

Veccia A, Caffo O, De Giorgi U, Di Lorenzo G, Ortega C, Scognamiglio F, Aieta M, Facchini G, Mansueto G, Mattioli R, Procopio G, Zagonel V, D'Angelo A, Spizzo G, Bortolus R, Donini M, Lo Re G, Massari F, Vicario G, Zucali PA, Alesini D, Bonetti A, Mucciarini C, Nicodemo M, Berruti A, Fratino L, Lodde M, Messina C, Perin A, Santini D, Sava T, Tucci M, Basso U, Maines F, Burgio LS, Galligioni E.

Future Oncol. 2016 Feb;12(4):493-502. doi: 10.2217/fon.15.302. Epub 2016 Jan 18.

PMID:
26776493
10.

Risk of Monozygotic Twins After Assisted Reproduction: A Population-Based Approach.

Parazzini F, Cipriani S, Bianchi S, Bulfoni C, Bortolus R, Somigliana E.

Twin Res Hum Genet. 2016 Feb;19(1):72-6. doi: 10.1017/thg.2015.96. Epub 2016 Jan 8.

PMID:
26743848
11.

Patterns of prescription and adherence to European Association of Urology guidelines on androgen deprivation therapy in prostate cancer: an Italian multicentre cross-sectional analysis from the Choosing Treatment for Prostate Cancer (CHOICE) study.

Morgia G, Russo GI, Tubaro A, Bortolus R, Randone D, Gabriele P, Trippa F, Zattoni F, Porena M, Mirone V, Serni S, Del Nero A, Lay G, Ricardi U, Rocco F, Terrone C, Pagliarulo A, Ludovico G, Vespasiani G, Brausi M, Simeone C, Novella G, Carmignani G, Leonardi R, Pinnarò P, De Paula U, Corvò R, Tenaglia R, Siracusano S, Mantini G, Gontero P, Savoca G, Ficarra V; (Members of the LUNA Foundation, Società Italiana d'Urologia)..

BJU Int. 2016 Jun;117(6):867-73. doi: 10.1111/bju.13307. Epub 2015 Sep 23.

PMID:
26332130
12.

Association of Rewarming Rate on Neonatal Outcomes in Extremely Low Birth Weight Infants with Hypothermia.

Rech Morassutti F, Cavallin F, Zaramella P, Bortolus R, Parotto M, Trevisanuto D.

J Pediatr. 2015 Sep;167(3):557-61.e1-2. doi: 10.1016/j.jpeds.2015.06.008. Epub 2015 Jul 10.

PMID:
26168772
13.

Web-based surveillance of public information needs for informing preconception interventions.

D'Ambrosio A, Agricola E, Russo L, Gesualdo F, Pandolfi E, Bortolus R, Castellani C, Lalatta F, Mastroiacovo P, Tozzi AE.

PLoS One. 2015 Apr 16;10(4):e0122551. doi: 10.1371/journal.pone.0122551. eCollection 2015.

14.

Prevention of congenital malformations and other adverse pregnancy outcomes with 4.0 mg of folic acid: community-based randomized clinical trial in Italy and the Netherlands.

Bortolus R, Blom F, Filippini F, van Poppel MN, Leoncini E, de Smit DJ, Benetollo PP, Cornel MC, de Walle HE, Mastroiacovo P; Italian and Dutch folic acid trial study groups..

BMC Pregnancy Childbirth. 2014 May 13;14:166. doi: 10.1186/1471-2393-14-166.

15.

Folic acid supplementation and preterm birth: results from observational studies.

Mantovani E, Filippini F, Bortolus R, Franchi M.

Biomed Res Int. 2014;2014:481914. doi: 10.1155/2014/481914. Epub 2014 Mar 3. Review.

16.

[Radiation therapy in locally advanced and/or relapsed urological tumors].

Bortolus R.

Urologia. 2013 Jul-Sep;80(3):212-24. doi: 10.5301/RU.2013.11501. Epub 2013 Sep 30. Italian.

PMID:
24526598
17.
18.

Real-world cabazitaxel safety: the Italian early-access program in metastatic castration-resistant prostate cancer.

Bracarda S, Gernone A, Gasparro D, Marchetti P, Ronzoni M, Bortolus R, Fratino L, Basso U, Mazzanti R, Messina C, Tucci M, Boccardo F, Cartenì G, Pinto C, Fornarini G, Mattioli R, Procopio G, Chiuri V, Scotto T, Dondi D, Di Lorenzo G.

Future Oncol. 2014 May;10(6):975-83. doi: 10.2217/fon.13.256. Epub 2013 Dec 3.

19.

Temporal trends and determinants of peripartum hysterectomy in Lombardy, Northern Italy, 1996-2010.

Parazzini F, Ricci E, Cipriani S, Chiaffarino F, Bortolus R, Chiantera V, Bulfoni G.

Arch Gynecol Obstet. 2013 Feb;287(2):223-8. doi: 10.1007/s00404-012-2547-4. Epub 2012 Sep 19.

PMID:
22990474
20.

Central nervous system metastases from castration-resistant prostate cancer in the docetaxel era.

Caffo O, Gernone A, Ortega C, Sava T, Cartenì G, Facchini G, Re GL, Amadio P, Bortolus R, Pagliarulo V, Prati V, Veccia A, Galligioni E.

J Neurooncol. 2012 Mar;107(1):191-6. doi: 10.1007/s11060-011-0734-y. Epub 2011 Oct 12.

PMID:
21989810

Supplemental Content

Loading ...
Support Center